RecruitingNot ApplicableNCT04936009

Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)

Noninvasive Brain Stimulation to Treat Core Social Deficits in Autism Spectrum Disorder

Sponsor

Yale University

Enrollment

60 participants

Start Date

Mar 17, 2022

Study Type

INTERVENTIONAL

Conditions

Autism Spectrum Disorder

Summary

This is a randomized interventional study designed to evaluate the effects of repetitive Transcranial Magnetic Stimulation (rTMS) on neural and behavioral facets of social cognition in adults with autism spectrum disorder (ASD).

Eligibility

Min Age: 18 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Transcranial Magnetic Stimulation (TMS) for people with autism spectrum disorder. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 40 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.